The role of nurses in strengthening cancer care in Africa

Dr Florence Manjuh - Mboppi Baptist Hospital, Douala, Cameroon
The role of nurses in strengthening cancer care in Africa ( Dr Florence Manjuh - Mboppi Baptist Hospital, Douala, Cameroon )
19 Jan 2026

Addressing late presentation in cervical cancer through community awareness

Dr Nomonde Mbatani - University of Cape Town, Cape Town, South Africa
Addressing late presentation in cervical cancer through community awareness ( Dr Nomonde Mbatani - University of Cape Town, Cape Town, South Africa )
19 Jan 2026

BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer

Dr Wala Ben Kridis - Habib Bourguiba Hospital, Sfax, Tunisia
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer ( Dr Wala Ben Kridis - Habib Bourguiba Hospital, Sfax, Tunisia )
14 Jan 2026

Key insights on breast cancer in Cape Verde

Dr Pamela Borges - Agostinho Neto University Hospital, Praia, Cape Verde
Key insights on breast cancer in Cape Verde ( Dr Pamela Borges - Agostinho Neto University Hospital, Praia, Cape Verde )
12 Jan 2026

SABCS 2025: Latest developments in multigene testing in early breast cancer

Prof Nadia Harbeck and Prof Giuseppe Curigliano
SABCS 2025: Latest developments in multigene testing in early breast cancer ( Prof Nadia Harbeck and Prof Giuseppe Curigliano )
5 Jan 2026

Multimodal AI model augments Oncotype DX in predicting distant recurrence in HR+/HER2 node negative BC

Dr Joseph Sparano - Icahn School of Medicine at Mount Sinai, New York, USA
Multimodal AI model augments Oncotype DX in predicting distant recurrence in HR+/HER2 node negative BC ( Dr Joseph Sparano - Icahn School of Medicine at Mount Sinai, New York, USA )
22 Dec 2025

Higher tumour-infiltrating lymphocytes predict better pathologic response in HER2-positive breast cancer

Prof Sunil Badve - Emory University, Atlanta, USA
Higher tumour-infiltrating lymphocytes predict better pathologic response in HER2-positive breast cancer ( Prof Sunil Badve - Emory University, Atlanta, USA )
22 Dec 2025

Tucatinib added to trastuzumab and pertuzumab improves PFS in first-line HER2-positive metastatic breast cancer

Dr Erika Hamilton - Sarah Cannon Research Institute, Nashville, USA
Tucatinib added to trastuzumab and pertuzumab improves PFS in first-line HER2-positive metastatic breast cancer ( Dr Erika Hamilton - Sarah Cannon Research Institute, Nashville, USA )
19 Dec 2025

Oncofertility counseling and fertility preservation in premenopausal women with early breast cancer

Dr Matteo Lambertini - University of Genova, Genova, Italy
Oncofertility counseling and fertility preservation in premenopausal women with early breast cancer ( Dr Matteo Lambertini - University of Genova, Genova, Italy )
18 Dec 2025

Aromatase inhibitors improve disease-free survival in HR+/HER2+ early breast cancer: ALTTO 10-year follow-up

Dr Matteo Lambertini - University of Genova, Genova, Italy
Aromatase inhibitors improve disease-free survival in HR+/HER2+ early breast cancer: ALTTO 10-year follow-up ( Dr Matteo Lambertini - University of Genova, Genova, Italy )
18 Dec 2025

Sacituzumab govitecan improves quality of life in untreated advanced TNBC

Dr Kevin Punie - Ziekenhuis aan de Stroom, Antwerp, Belgium
Sacituzumab govitecan improves quality of life in untreated advanced TNBC ( Dr Kevin Punie - Ziekenhuis aan de Stroom, Antwerp, Belgium )
18 Dec 2025

AI and pathology reveal higher late recurrence risk in invasive lobular breast cancer

Dr Roberto Salgado - Peter MacCallum Cancer Centre, Melbourne, Australia
AI and pathology reveal higher late recurrence risk in invasive lobular breast cancer ( Dr Roberto Salgado - Peter MacCallum Cancer Centre, Melbourne, Australia )
16 Dec 2025